TrialViruses2015

Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study.

Danielle P Porter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.